Global Orphan Lung Diseases Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

希少性肺疾患の治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

◆タイトル:Global Orphan Lung Diseases Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
◆商品コード:GIR8104815
◆調査・発行会社:Global Info Research
◆発行日:2018年9月14日
◆ページ数:124
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール
◆調査対象地域:世界
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥375,840見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥563,760見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥751,680見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは、希少性肺疾患の治療の世界市場について調べ、まとめました。種類別セグメントは、免疫抑制剤、抗炎症薬、抗線維化剤、血管拡張薬、コルチコステロイド、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。希少性肺疾患の治療の世界市場概観、メーカー動向、メーカー別希少性肺疾患の治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・希少性肺疾患の治療の市場概観
・希少性肺疾患の治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・希少性肺疾患の治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・希少性肺疾患の治療の世界市場規模
・希少性肺疾患の治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・希少性肺疾患の治療のアメリカ市場規模推移
・希少性肺疾患の治療のカナダ市場規模推移
・希少性肺疾患の治療のメキシコ市場規模推移
・希少性肺疾患の治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・希少性肺疾患の治療のドイツ市場規模推移
・希少性肺疾患の治療のイギリス市場規模推移
・希少性肺疾患の治療のロシア市場規模推移
・希少性肺疾患の治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・希少性肺疾患の治療の日本市場規模推移
・希少性肺疾患の治療の中国市場規模推移
・希少性肺疾患の治療の韓国市場規模推移
・希少性肺疾患の治療のインド市場規模推移
・希少性肺疾患の治療の東南アジア市場規模推移
・希少性肺疾患の治療の南米市場分析(ブラジル、アルゼンチン等)
・希少性肺疾患の治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・希少性肺疾患の治療の種類別分析/市場規模推移(免疫抑制剤、抗炎症薬、抗線維化剤、血管拡張薬、コルチコステロイド、その他)
・希少性肺疾患の治療の用途別分析/市場規模推移(病院薬局、小売薬局、オンライン薬局)
・希少性肺疾患の治療の市場予測(地域別予測、種類別予測、用途別予測)
・希少性肺疾患の治療の販売チャネル・代理店・貿易業者・ディーラー分析

Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.

Scope of the Report:

This report studies the Orphan Lung Diseases Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Orphan Lung Diseases Treatment market by product type and applications/end industries.

Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are endemic to regions mainly in Africa, Asia and the Americas.

It is to be expected that the global market of orphan lung disease treatment will show steady growth. Pharmaceutical and medical industries have gained huge profit by generating new drugs for treatment of orphan lung diseases. High number of new product and therapies are entering the market which impose can impose the growth globally.

The global Orphan Lung Diseases Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Orphan Lung Diseases Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

GSK

Pfizer

Celgene

Novartis

NPS Pharmaceuticals

Auspex Pharmaceuticals

Synageva BioPharma

Roche

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Immunosuppressants

Anti-Inflammatory Drugs

Anti-Fibrotic Agents

Vasodilators

Corticosteroids

CFTR Modulators

Others

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

【レポートの目次】

Table of Contents

1 Orphan Lung Diseases Treatment Market Overview

1.1 Product Overview and Scope of Orphan Lung Diseases Treatment

1.2 Classification of Orphan Lung Diseases Treatment by Types

1.2.1 Global Orphan Lung Diseases Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Orphan Lung Diseases Treatment Revenue Market Share by Types in 2017

1.2.3 Immunosuppressants

1.2.4 Anti-Inflammatory Drugs

1.2.5 Anti-Fibrotic Agents

1.2.6 Vasodilators

1.2.7 Corticosteroids

1.2.8 CFTR Modulators

1.2.9 Others

1.3 Global Orphan Lung Diseases Treatment Market by Application

1.3.1 Global Orphan Lung Diseases Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Orphan Lung Diseases Treatment Market by Regions

1.4.1 Global Orphan Lung Diseases Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Orphan Lung Diseases Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Orphan Lung Diseases Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Orphan Lung Diseases Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Orphan Lung Diseases Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Orphan Lung Diseases Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Orphan Lung Diseases Treatment (2013-2023)

2 Manufacturers Profiles

2.1 GSK

2.1.1 Business Overview

2.1.2 Orphan Lung Diseases Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GSK Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Orphan Lung Diseases Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Celgene

2.3.1 Business Overview

2.3.2 Orphan Lung Diseases Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Celgene Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Orphan Lung Diseases Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 NPS Pharmaceuticals

2.5.1 Business Overview

2.5.2 Orphan Lung Diseases Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 NPS Pharmaceuticals Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Auspex Pharmaceuticals

2.6.1 Business Overview

2.6.2 Orphan Lung Diseases Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Auspex Pharmaceuticals Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Synageva BioPharma

2.7.1 Business Overview

2.7.2 Orphan Lung Diseases Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Synageva BioPharma Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Roche

2.8.1 Business Overview

2.8.2 Orphan Lung Diseases Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Roche Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Orphan Lung Diseases Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Orphan Lung Diseases Treatment Market Competition, by Players

3.1 Global Orphan Lung Diseases Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Orphan Lung Diseases Treatment Players Market Share

3.2.2 Top 10 Orphan Lung Diseases Treatment Players Market Share

3.3 Market Competition Trend

4 Global Orphan Lung Diseases Treatment Market Size by Regions

4.1 Global Orphan Lung Diseases Treatment Revenue and Market Share by Regions

4.2 North America Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

5 North America Orphan Lung Diseases Treatment Revenue by Countries

5.1 North America Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

5.2 USA Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

6 Europe Orphan Lung Diseases Treatment Revenue by Countries

6.1 Europe Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

6.2 Germany Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

6.4 France Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Orphan Lung Diseases Treatment Revenue by Countries

7.1 Asia-Pacific Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

7.2 China Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

7.5 India Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

8 South America Orphan Lung Diseases Treatment Revenue by Countries

8.1 South America Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

8.2 Brazil Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Orphan Lung Diseases Treatment by Countries

9.1 Middle East and Africa Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

10 Global Orphan Lung Diseases Treatment Market Segment by Type

10.1 Global Orphan Lung Diseases Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Orphan Lung Diseases Treatment Market Forecast by Type (2018-2023)

10.3 Immunosuppressants Revenue Growth Rate (2013-2023)

10.4 Anti-Inflammatory Drugs Revenue Growth Rate (2013-2023)

10.5 Anti-Fibrotic Agents Revenue Growth Rate (2013-2023)

10.6 Vasodilators Revenue Growth Rate (2013-2023)

10.7 Corticosteroids Revenue Growth Rate (2013-2023)

10.8 CFTR Modulators Revenue Growth Rate (2013-2023)

10.9 Others Revenue Growth Rate (2013-2023)

11 Global Orphan Lung Diseases Treatment Market Segment by Application

11.1 Global Orphan Lung Diseases Treatment Revenue Market Share by Application (2013-2018)

11.2 Orphan Lung Diseases Treatment Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 Online Pharmacies Revenue Growth (2013-2018)

12 Global Orphan Lung Diseases Treatment Market Size Forecast (2018-2023)

12.1 Global Orphan Lung Diseases Treatment Market Size Forecast (2018-2023)

12.2 Global Orphan Lung Diseases Treatment Market Forecast by Regions (2018-2023)

12.3 North America Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

12.6 South America Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Orphan Lung Diseases Treatment Picture

Table Product Specifications of Orphan Lung Diseases Treatment

Table Global Orphan Lung Diseases Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Orphan Lung Diseases Treatment Revenue Market Share by Types in 2017

Figure Immunosuppressants Picture

Figure Anti-Inflammatory Drugs Picture

Figure Anti-Fibrotic Agents Picture

Figure Vasodilators Picture

Figure Corticosteroids Picture

Figure CFTR Modulators Picture

Figure Others Picture

Table Global Orphan Lung Diseases Treatment Revenue (Million USD) by Application (2013-2023)

Figure Orphan Lung Diseases Treatment Revenue Market Share by Applications in 2017

Figure Hospital Pharmacies Picture

Figure Retail Pharmacies Picture

Figure Online Pharmacies Picture

Table Global Market Orphan Lung Diseases Treatment Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Orphan Lung Diseases Treatment Type and Applications

Table GSK Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Orphan Lung Diseases Treatment Type and Applications

Table Pfizer Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Orphan Lung Diseases Treatment Type and Applications

Table Celgene Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Orphan Lung Diseases Treatment Type and Applications

Table Novartis Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table NPS Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table NPS Pharmaceuticals Orphan Lung Diseases Treatment Type and Applications

Table NPS Pharmaceuticals Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Auspex Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Auspex Pharmaceuticals Orphan Lung Diseases Treatment Type and Applications

Table Auspex Pharmaceuticals Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Synageva BioPharma Basic Information, Manufacturing Base and Competitors

Table Synageva BioPharma Orphan Lung Diseases Treatment Type and Applications

Table Synageva BioPharma Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Orphan Lung Diseases Treatment Type and Applications

Table Roche Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Orphan Lung Diseases Treatment Type and Applications

Table Sanofi Orphan Lung Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Global Orphan Lung Diseases Treatment Revenue (Million USD) by Players (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue Share by Players (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Share by Players in 2016

Figure Global Orphan Lung Diseases Treatment Revenue Share by Players in 2017

Figure Global Top 5 Players Orphan Lung Diseases Treatment Revenue Market Share in 2017

Figure Global Top 10 Players Orphan Lung Diseases Treatment Revenue Market Share in 2017

Figure Global Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue (Million USD) by Regions (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Market Share by Regions in 2017

Figure North America Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Europe Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure South America Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table North America Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

Table North America Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Orphan Lung Diseases Treatment Revenue Market Share by Countries in 2017

Figure USA Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Canada Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Mexico Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table Europe Orphan Lung Diseases Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Europe Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure Europe Orphan Lung Diseases Treatment Revenue Market Share by Countries in 2017

Figure Germany Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure UK Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure France Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Russia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Italy Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Orphan Lung Diseases Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Orphan Lung Diseases Treatment Revenue Market Share by Countries in 2017

Figure China Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Japan Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Korea Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure India Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table South America Orphan Lung Diseases Treatment Revenue by Countries (2013-2018)

Table South America Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Orphan Lung Diseases Treatment Revenue Market Share by Countries in 2017

Figure Brazil Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Argentina Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Colombia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Orphan Lung Diseases Treatment Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Orphan Lung Diseases Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Orphan Lung Diseases Treatment Revenue Market Share by Countries in 2017

Figure Saudi Arabia Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure UAE Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Egypt Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure Nigeria Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Figure South Africa Orphan Lung Diseases Treatment Revenue and Growth Rate (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue (Million USD) by Type (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue Share by Type (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Share by Type (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Share by Type in 2017

Table Global Orphan Lung Diseases Treatment Revenue Forecast by Type (2018-2023)

Figure Global Orphan Lung Diseases Treatment Market Share Forecast by Type (2018-2023)

Figure Global Immunosuppressants Revenue Growth Rate (2013-2018)

Figure Global Anti-Inflammatory Drugs Revenue Growth Rate (2013-2018)

Figure Global Anti-Fibrotic Agents Revenue Growth Rate (2013-2018)

Figure Global Vasodilators Revenue Growth Rate (2013-2018)

Figure Global Corticosteroids Revenue Growth Rate (2013-2018)

Figure Global CFTR Modulators Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue by Application (2013-2018)

Table Global Orphan Lung Diseases Treatment Revenue Share by Application (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Share by Application (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue Share by Application in 2017

Table Global Orphan Lung Diseases Treatment Revenue Forecast by Application (2018-2023)

Figure Global Orphan Lung Diseases Treatment Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Orphan Lung Diseases Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Orphan Lung Diseases Treatment Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Orphan Lung Diseases Treatment Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

Figure Europe Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

Figure South America Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Orphan Lung Diseases Treatment Revenue Market Forecast (2018-2023)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[希少性肺疾患の治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (Global Orphan Lung Diseases Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 / GIR8104815)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆